HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathan Scott Selected Research

Nathan Scott Research Topics

Disease

3Neoplasms (Cancer)
03/2024 - 03/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2024
1Cytomegalovirus Retinitis
03/2024
1Opportunistic Infections (Opportunistic Infection)
03/2024
1Retinitis
03/2024
1Retinal Detachment (Retinal Detachments)
07/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Deglutition Disorders (Dysphagia)
01/2020
1Blindness (Hysterical Blindness)
06/2017
1Burns
06/2017
1Inflammation (Inflammations)
06/2017
1Dyslipidemias (Dyslipidemia)
05/2014
1Neoplasm Metastasis (Metastasis)
03/2012
1Lung Neoplasms (Lung Cancer)
03/2012

Drug/Important Bio-Agent (IBA)

1ValganciclovirFDA Link
03/2024
1Chimeric Antigen ReceptorsIBA
03/2024
1Silicone OilsIBA
07/2023
1Gefitinib (Iressa)FDA Link
01/2022
1SolutionsIBA
01/2020
1Oxygen (Dioxygen)IBA
06/2017
1CytokinesIBA
06/2017
1AlkaliesIBA
06/2017
1Retinaldehyde (Retinal)IBA
06/2017
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2017
1Monoclonal AntibodiesIBA
06/2017
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
05/2014
1TriazinesIBA
05/2014
1Immunoconjugates (Immunoconjugate)IBA
01/2013
1OsteopontinIBA
03/2012
1Carboplatin (JM8)FDA LinkGeneric
03/2012

Therapy/Procedure

2Therapeutics
03/2024 - 06/2017